Treatment May Involve Inhibiting Mitochondria Toxins - Brain Scans May
Help Predict the Degenerative Disease
May 1st 2006
Scientists have identified the key gene locations in brain cells where
significant damage occurs in patients with Alzheimer’s disease.
Researchers at the Oregon Health & Science University's Neurological
Sciences Institute (NSI) believe that this could lead to a possible
target for future therapies.
The results, published in the May 1st issue of the journal
Human Molecular Genetics, identify mitochondria structures inside cells
as being heavily involved in the degenerative disease. The researchers
believe that toxins created by the mitochondria contribute to the
Dr. P. Hemachandra Reddy said “This latest research more clearly
demonstrates how structures, called mitochondria, in brain cells are a
key part of the disease process in Alzheimer's. In fact, mitochondria
appear to be a site where significant disease progression takes place."